{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-195148","form_type":"8-K","ticker":"PROK","cik":"0001850270","company_name":"PROKIDNEY CORP.","filed_at":"2022-07-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.444508+00:00","generated_at":"2026-06-24T14:24:50.567408+00:00","sec_items":["1.01","2.01","9.01","5.02","4.01","3.02","3.03","5.01","5.03","5.06","8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"ProKidney completes de-SPAC merger; begins trading as PROK on Nasdaq","bullets":["Social Capital Suvretta Holdings Corp. III merged with ProKidney LP; renamed ProKidney Corp.","~22.8M public shares redeemed at ~$10.00 each, leaving ~$21.7M in trust post-closing.","Outstanding equity after close: 9.06M Class A shares from SPAC holders and 52.48M Class A shares from PIPE.","Class A ordinary shares began trading under ticker PROK on Nasdaq on July 12, 2022.","Lock-up restrictions range from 30 days to 4 years, with earn-out milestones at $12.50 and $15.00 per share."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-195148","json":"https://secwatch.observer/filing/0001193125-22-195148.json","markdown":"https://secwatch.observer/filing/0001193125-22-195148.md","text":"https://secwatch.observer/filing/0001193125-22-195148.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850270/000119312522195148/0001193125-22-195148-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850270/000119312522195148/d285643d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T14:24:50.567408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05346e3098","claim":"Jennifer Fox was appointed as member of the board of directors at PROKIDNEY CORP..","evidence_excerpt":"On July 11, 2022, the New ProKidney board of directors appointed Jennifer Fox as a member of the board of directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312522195148/0001193125-22-195148-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"member of the board of directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}